Maroon
Catalytic
Growth
Capital

Maroon Catalytic Growth Capital

Advancing Healthy Aging & Healthspan‍

reversing material innovation & funding gaps in Preventative Health to reduce chronic Population Health conditions and direct Climate Impact on Health
Maroon Catalytic Growth Capital headquartered globally out of Singapore, Hong Kong, and the USA; makes anchor investments (across later stage Venture & Growth Capital) to accelerate Healthy Longevity & HealthSpan Science innovation and infrastructure by closing material innovation and funding gaps in proactive, personalized Preventative Healthcare & Precision Medicine addressing chronic Population Health conditions.
‍
Areas include critical diagnostics and therapeutics to support Neurological & Brain Health, Autoimmune & Metabolic Health, Cardiovascular-Blood Health, and direct Climate Impact on Health including Exposomes.

The Fund prioritises innovation leveraging Artificial Intelligence & Digital Infrastructure, as well as, physical health-enabling Infrastructure for optimal health outcomes and execution delivery.

Maroon also manages Maroon Venture Fund I LP - a US-only venture capital fund investing anchor capital at Seed to Series A+.
Advancing Healthy Aging &Longevity

Advancing Healthy Aging &Longevity

through priority on personalised Preventative Health measures
Climate Impact on Health

Climate Impact on Health

through authentic, measurable innovation in the Built Environment, Blue Economy, and AI-driven Climate solutions
Deep Fundamentals  Diligence Leadership

Deep Fundamentals Diligence Leadership

complements extensive portfolio credit/risk expertise and portfolio construction providing greater risk mitigation and downside protection for LPs
Strong Investment Track Record

Strong Investment Track Record

Team collectively has an impressive track record in early-stage venture scaling, investments, IPOs, and successful exits across Health and Climate ventures